According to Daniel J. Klein, president and CEO of the Patient Access Network Foundation, patients now have an easier time accessing the high-cost treatments they need, thanks to certain policies and programs. Klein also anticipates that a recently-passed law will bring down the prices of some prescription drugs.
According to Daniel J. Klein, president and CEO of the Patient Access Network (PAN) Foundation, patients now have an easier time accessing the high-cost treatments they need, thanks to certain policies and programs. Klein also anticipates that a recently-passed law will bring down the prices of some prescription drugs.
Transcript (slightly modified)
What are the major ways patients can get access to costly medications?
Today, most patients do have some form of health insurance, which is great. Usually, there’s coverage available for even high-cost medications through the various health insurance plans that patient have. Where it becomes challenging is when the health insurance plan may have a high deductible, or co-pay, or co-insurance, and in that case, some patients need additional assistance.
Many patients rely on assistance from the drug manufacturer in the form of a coupon or a co-pay card. Then, patients particularly in Medicare and other federal insurance programs may need to come to a charitable assistance program, like the PAN Foundation. But, by and large, as a result of the Affordable Care Act and the expansion of Medicaid, most people do have access to the treatment that they need.
What impact do you expect the 21st Century Cures Act to have on improving access to medications?
Clearly, the process for approving generic drugs has been slower than most people would like. The high cost of some drugs may be reduced through competition through generics, so I think that there’s every reason to hope that the 21st Century Cures Act will improve the affordability, at least, of some medications, and in that way improve access.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More